Gonadal function in long term survivors with B thalassemia major following bone marrow transplantation.
De Sanctis
V
V
Divisione di Pediatria e Medicina Nucleare, Arcispedale S. Anna, Ferrara, Italia.
Galimberti
M
M
Lucarelli
G
G
Angelucci
E
E
Ughi
M
M
Baronciani
D
D
Polchi
P
P
Giardini
C
C
Vullo
C
C
Bagni
B
B
D000293:Adolescent; D016465:Bone Marrow Purging / Q000009:adverse effects*; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005500:Follow-Up Studies; D007987:Gonadotropin-Releasing Hormone; D006130:Growth Disorders / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D011628:Puberty, Delayed / Q000097:blood / Q000209:etiology*; D017086:beta-Thalassemia / Q000150:complications / Q000628:therapy*
D007166:Immunosuppressive Agents; D007987:Gonadotropin-Releasing Hormone; D003520:Cyclophosphamide; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D002066:Busulfan